HYPR

0.54654.27%
MD

Maria Degois-Sainz

CEO, President & Director

Ms. Maria Degois-Sainz is Independent Director of Pulse Biosciences, Inc. from January 08, 2026. Ms. Degois-Sainz is Chair of the Board of Onera Technologies B.V. from January 2025. Ms. Degois-Sainz serves as Executive Chairwoman of Levita Magnetics International Corp. since August 2022. Ms. Degois-Sainz serves as the Chief Executive Officer, Hyperfine, Inc. since October 2022. She served as Independent Director at Atrion Corporation from August 30, 2021 until October 21, 2022. She serves as Independent Director at TISSIUM S. A. since August 2022. She served as Independent Director of Shockwave Medical, Inc. since July 2020 until May 31, 2024. She had been Chief Executive Officer and President of Aegea Medical Inc. since May 2018 until February 2021 and serves as its Director. Ms. Degois-Sainz had been Director of IRIDEX Corp. since April 13, 2018 until June 24, 2020. She is an Independent Director at Hyperfine, Inc. since December 2021. Ms. Degois-Sainz has experience in the medical device industry having held commercial and general management positions both in the United States and Europe. At Concentric Medical, Inc., she served as the Chief Executive Officer and President from October 2011 until May 2012, where she contributed to ramping revenues to several amount and negotiated the acquisition of the company by Stryker Corporation. From 2008 to 2011, she was President and Chief Executive Officer of Concentric Medical, Inc. Ms. Degois-Sainz began her medical technology career at Guidant Corporation (“Guidant”), where she held positions of increasing responsibility in Europe and the United States. She served as the President of the Cardiac Surgery division of Guidant Corporation from 2003 to 2006 at the time of the companys acquisition by Boston Scientific, at which point she continued as an advisor to Boston Scientific. Ms. Degois-Sainz has been intimately involved in several major medical technology product launches such as coronary stents and cardiac resynchronization therapy devices. She led the integration process for both the Cardiac Surgery and European Cardiac Rhythm Management business of Guidant into Boston Scientific. She served as General Manager of Stryker Neurovascular until 2012. From 2001 to 2003, she served as Vice President of Global Marketing for Vascular Intervention at Guidant and Vice President, Intermedics Cardiac Rhythm Management in Europe. She began her career at Eli Lilly & Co. From 1991 to 2006, Ms. Degois-Sainz held various executive positions in the United States and Europe within the cardiac rhythm management, cardiac surgery and vascular intervention divisions of Eli Lilly's medical device businesses and Guidant Corporation. She had been an Independent Director of The Spectranetics Corporation since November 03, 2010 until August 2017. She served as an Independent Director of MRI Interventions, Inc. from January 06, 2014 to May 17, 2018. She serves as Director of Levita Magnetics International Corp. She serves as a Director at CardioKinetix, Inc. Ms. Degois-Sainz served as the President, Chief Executive Officer and Director of CardioKinetix Inc., a private company that developed transcatheter implants from May 2012 to July 2017. She had been an Independent Director of Avanos Medical, Inc. (formerly known as Halyard Health, Inc.) since February 1, 2015 until January 01, 2023. She served as Director of Orthofix Medical Inc. (formerly known as Orthofix International N. V.) since November 27, 2012 until June 21, 2021 and served the same position from June 2008 to September 21, 2011. She served as a Director of Concentric Medical, Inc. from April 2008 to May 2012. She served as a Director of NeoTract, Inc. Ms. Degois-Sainz earned a Bachelor and Masters of Arts in Languages from the Universidad Complutense de Madrid and a Master's Degree in International Management from American Graduate School of International Management.

公司職務